Table. Patient Demographics in 2018, 2019, and 2020.
| Characteristic | Patients | ||
|---|---|---|---|
| 2018 (n = 1 400 657) | 2019 (n = 1 437 754) | 2020 (n = 1 229 654) | |
| Age, median (IQR), y | 66 (57-74) | 66 (57-74) | 66 (57-74) |
| Sex, No. (%) | |||
| Female | 753 831 (53.8) | 770 524 (53.6) | 661 872 (53.8) |
| Male | 646 371 (46.1) | 666 779 (46.4) | 567 151 (46.1) |
| Unknown | 455 (0.1) | 451 (<0.1) | 631 (0.1) |
| Race and ethnicity, No. (%) | |||
| Asian, Native Hawaiian, or Other Pacific Islander | 48 551 (3.5) | 50 900 (3.5) | 43 033 (3.5) |
| Hispanic | 91 936 (6.6) | 96 178 (6.7) | 81 955 (6.7) |
| Non-Hispanic Black | 153 693 (11.0) | 158 773 (11.0) | 135 555 (11.0) |
| Non-Hispanic White | 1 060 226 (75.7) | 1 085 244 (75.5) | 926 984 (75.4) |
| Other or unknowna | 46 251 (3.3) | 46 659 (3.3) | 42 127 (3.4) |
| Most common disease sites, No. (%) | |||
| Breast | 260 284 (18.6) | 268 193 (18.7) | 233 331 (19.0) |
| Lung | 163 342 (11.7) | 165 597 (11.5) | 140 355 (11.4) |
| Prostate | 144 490 (10.3) | 153 497 (10.7) | 124 822 (10.2) |
| Urinary system | 110 174 (7.9) | 113 733 (7.9) | 98 552 (8.0) |
| Female genital system | 88 191 (6.3) | 89 559 (6.2) | 78 250 (6.4) |
| Travel distance, median (IQR), mi | 11.1 (4.9-25.7) | 11.1 (5.0-25.7) | 11.1 (5.0-25.3) |
| Time to treatment, median (IQR), d | |||
| Overall | 27 (0-36) | 27 (0-37) | 26 (0-36) |
| Surgical | 26 (1-53) | 27 (1-55) | 26 (0-53) |
| Chemotherapy | 42 (21-56) | 42 (22-56) | 40 (21-54) |
| Radiation | 84 (41-103) | 85 (42-105) | 83 (41-104) |
a
Other or unknown, according to the National Cancer Database data dictionary, was defined by the lack of documentation of the patient’s race or ethnicity. Because race or ethnicity was not stated in the patient’s record, it was coded as other or unknown by a certified tumor registrar for data abstraction.